PHARMA MAR, S.A. The price-sensitive information presented in other languages is a literal translation of the price-sensitive information stated in Spanish 15/11/2017 08:12 PHARMA MAR, S.A. R&D: new licenses, patents and registered trademarks After analysis of the safety data of the first 150 patients, IDMC recommends that the Phase III trial with Zepsyre® in small-cell lung cancer patients should continue without any changes Register number: 258531
